Bristol Myers Squibb Stock Investor Sentiment

BMY Stock  USD 58.78  0.09  0.15%   
Slightly above 57% of Bristol Myers' investor base is looking to short. The analysis of overall sentiment of trading Bristol Myers Squibb stock suggests that many investors are alarmed at this time. Bristol Myers' investing sentiment can be driven by a variety of factors including economic data, Bristol Myers' earnings reports, geopolitical events, and overall market trends.

Panic Vs Confidence

43

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Bristol Myers' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Bristol Myers Squibb.

Bristol Historical Sentiment

Although Bristol Myers' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Bristol, such as negative comments on social media and news outlets, may cause fear in the market and push Bristol Myers' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Bristol.
  

Bristol Myers Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Bristol Myers can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Bristol Myers Squibb Historical Investor Sentiment

Investor biases related to Bristol Myers' public news can be used to forecast risks associated with an investment in Bristol. The trend in average sentiment can be used to explain how an investor holding Bristol can time the market purely based on public headlines and social activities around Bristol Myers Squibb. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bristol Myers' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bristol Myers and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Bristol Myers news discussions. The higher the estimate score, the more favorable the investor's outlook on Bristol Myers.
six days ago at bbc.co.uk         
Tom Jordan Scotland international to join Bristol Bears from Glasgow Warriors
news
six days ago at deadline.com         
Oscars Academypresents GovernorsAwards In Starry And Emotional Night
news
over a week ago at bbc.co.uk         
Homecoming for Bristol actor in Hippodromes Mary Poppins musical
news
over a week ago at bnnbloomberg.ca         
Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says
bloomberg News
over a week ago at bbc.co.uk         
Bristol in pictures Mary Poppins, Armistice Day and Red Rebels
news
over a week ago at thelincolnianonline.com         
Bristol-Myers Squibb Shares Sold by KPP Advisory Services LLC
news
over a week ago at bbc.co.uk         
Bristol charity to get 30 homeless people housed in flats
news
over a week ago at thelincolnianonline.com         
KCM Investment Advisors LLC Reduces Holdings in Bristol-Myers Squibb
news
over a week ago at gurufocus.com         
Bristol-Myers Squibb Co Trading Down 3.9 percent on Nov 16
Gurufocus Stories at Macroaxis
over a week ago at deadline.com         
Thelma Filmmaker Says Grandmother, And June Squibb, Powered the Story
news
over a week ago at seekingalpha.com         
Bristol Myers gets positive EMA opinion for repotrectinib
seekingalpha News
over a week ago at benzinga.com         
Bristol-Myers Faces Renewed 6.7 Billion Lawsuit Over Drug Approval Delays Amid Resolved Trustee Issu...
benzinga news
over a week ago at aol.com         
Man and four tooled up teens guilty of murdering two Bristol boys in case of mistaken identity
news
over a week ago at medcitynews.com         
Halozyme Makes Unsolicited 2B Takeover Bid for Drug RD Services Firm Evotec
news
over a week ago at bbc.co.uk         
Mason Rist and Max Dixon Five guilty of murdering Bristol teens
news
Far too much social signal, news, headlines, and media speculation about Bristol Myers that are available to investors today. That information is available publicly through Bristol media outlets and privately through word of mouth or via Bristol internal channels. However, regardless of the origin, that massive amount of Bristol data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bristol Myers news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bristol Myers relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bristol Myers' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bristol Myers alpha.

Bristol Myers Performance against Dow Jones

 Price Growth (%)  
       Timeline  
 
Bristol Myers dividend paid on 1st of November 2024
11/01/2024
1
Bristol-Myers Squibb Shares Sold by Harvest Portfolios Group Inc.
11/06/2024
2
AbbVie Stock Drops 12 percent On Schizophrenia Drug Setback Should You Buy The Dip
11/11/2024
3
Gregor Townsend says Tom Jordan can keep improving with Bristol
11/14/2024
4
Tom Jordan Scotland international to join Bristol Bears from Glasgow Warriors
11/18/2024
5
Bristol-Myers Squibb Shares Acquired by Meeder Advisory Services Inc.
11/19/2024
6
Bristol drugs operation leads to multiple charges
11/20/2024
7
Bristol Awarded 113K To Plant 238 Trees Around Town
11/21/2024
8
AlSaeed to acquire Al Qadi shares in Bristol Rovers
11/22/2024

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.